The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
380 jobs Number of planned job losses
Announcement Date
9 February 2010
Employment effect (start)
9 February 2010
Foreseen end date
Description
380 jobs to go as GlaxoSmithKline closes its research unit in Harlow, Essex. The losses come as projects for pain relief, anxiety and depression drugs end, and no further research is planned. The company says a consultation period is under way, and that to acheive a £500m saving by 2012 it would continue to restructure, but with a minimum of job losses. The firm announced a 12% rise in annual profit on 4 February 2010. No details were given regarding when the job losses would be completed by.
Sources
9 February 2010: BBC Website
Citation
Eurofound (2010), Glaxo Smith Kline, Internal restructuring in United Kingdom, factsheet number 70186, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/70186.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
